Almstead Neil Gregory bought PTCT
July 6, 2026 · Form 4 insider transaction
Almstead Neil Gregory bought 2,474 shares of PTC Therapeutics, Inc. at $39.42 per share, a transaction worth $97.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,474
Price
$39.42
Total value
$97.5K
InsiderAlmstead Neil Gregory
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 6, 2026
Filing dateJuly 8, 2026
Shares owned after62,773
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025.